You are here

Contact:
Jon Dobson
(202) 434-7272
jdobson@advamed.org
November 7, 2017

AdvaMed, the Investment Promotion Agency of the Ministry of Commerce, and the Chengdu Municipal People’s Government, Host 2017 MedTech Industry Strategic International Summit

CHENGDU, CHINA – The Advanced Medical Technology Association (AdvaMed), together with the Investment Promotion Agency of the Ministry of Commerce, and the Chengdu Municipal People’s Government, today concluded a successful, jointly-organized MedTech Industry Strategic International Summit in Chengdu, Sichuan Province.

The Nov. 7 meeting was held to explore policies and innovations aimed at improving patient care and safety, including through expanded access to safe and effective solutions from the medical technology industry.

Over 200 people attended the Summit, including ministerial- and commission-level leaders from Chendgu and Sichuan, as well as China’s Ministry of Commerce, National Health and Family Planning Commission, CFDA, State Council Healthcare Reform Office, and the U.S. Consulate. Representatives from the Chinese Hospital Association, local hospitals and universities also participated.

“The Summit provided an excellent opportunity for participants to discuss the future development of the medical device industry in Chengdu and Sichuan Province, to build professional relationships, and to gain a deeper understanding of Chinese government policies, guidelines and direction that can help spur innovation in patient care and patient safety,” said AdvaMed President and CEO Scott Whitaker.

“As a result of this productive Summit, AdvaMed is in a better position to collaborate with China’s government and domestic medtech industry to achieve mutually beneficial goals, including improved access to high quality medical technologies that save and improve patients’ lives,” Whitaker said.

During the Summit, Chinese government officials and members of the AdvaMed China Board of Directors gathered to express their views on how best to work together to advance innovation in patient care and patient safety. They provided valuable input and suggestions on government health care policy and explored how governments of all localities can work with the device industry to expand and strengthen development of next-generation treatments and cures.  

The Summit was designed to align with China’s national health care policy objectives. Following commitments made by President Xi at the 19th Party Congress, AdvaMed and the medical device industry are ready to help support efforts to further deepen reforms in the health care sector and improve access to medical technology.